LUXA-D Recall - Foreign Capsule Found in Affected Batch
Summary
Jamp Pharma is recalling one batch of LUXA-D 2000 units capsules (Lot S2520177, DIN 02442256) from the Canadian market after a capsule containing a foreign product was found in the affected batch. The recall affects wholesalers at the distribution level. Healthcare providers and patients who have this product should verify their inventory and consult their healthcare provider before discontinuing use.
What changed
Jamp Pharma issued a Type III health product recall for LUXA-D 2000 units vitamin D3 capsules (Lot S2520177) following discovery of a foreign capsule in the affected batch. The recall targets wholesale distribution (depth of recall: Wholesalers). Identification number RA-81814. This is the least serious recall category with minimal health risk anticipated.
Wholesalers should verify if they have the affected lot in stock and contact Jamp Pharma regarding return procedures. Patients should check their product for lot number S2520177 and consult their healthcare provider before making any changes to their medication regimen. Healthcare providers should counsel patients accordingly and report any adverse events to Health Canada through the MedEffect program.
What to do next
- Verify if you have Lot S2520177 of LUXA-D 2000 units capsules in stock
- Consult your healthcare provider before discontinuing use of affected product
- Report any health product side effects or complaints to Health Canada
Archived snapshot
Apr 1, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Health product recall
LUXA-D: A capsule containing a foreign product was found in the affected batch.
Brand(s)
Last updated
2026-03-31
Summary
Product LUXA-D Issue Health products - Product safety What to do Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| LUXA-D | LUXA-D 2000 units capsules | DIN 02442256 | Capsules | Vitamine D3, 2000 units | S2520177 |
Issue
A capsule containing a foreign product was found in the affected batch.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers
Details
Original published date:
2026-03-31
Alert / recall type Health product recall Category Health products - Drugs Companies
Jamp Pharma.
1310 Nobel,
Boucherville, Qc,
J4B 5H3
Published by Health Canada Audience General public Healthcare Industry Recall class Type III Recall date
2026-03-31
Identification number RA-81814
Get notified
Receive emails about new and updated recall and safety alerts.
Related changes
Get daily alerts for Health Canada Recalls & Safety Alerts
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from Health Canada.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when Health Canada Recalls & Safety Alerts publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.